Joan Montero, PhD
Drug Discovery Advisor
Dr. Joan Montero is a Ramon y Cajal Senior Researcher at the Institute for Bioengineering of Catalonia (IBEC) and collaborator with Dana-Farber Cancer Institute, a Harvard Medical School affiliated hospital. His work at the IBEC currently consists in developing new tools and discover novel therapies for personalized cancer treatment combining his biomedical background and expertise in cell-based assays. As a scientist, Dr. Montero has always been interested in the process of programmed cell death because it can explain why some therapies are not effective in treating cancer patients.
He developed a new functional predictive biomarker to predict chemotherapy response in patient biopsies and personalize cancer therapy in many types of cancer at the Letai Lab – Dana-Farber Cancer Institute; this technology has been patented by Dana-Farber Cancer Institute.
Dr. Montero earned his PhD at the University of Barcelona and has published many articles in international peer-reviewed journals, including a Cell and Cancer Discovery publications, and achieved a remarkable impact (h-index: 15 and 1313 citations). He has received many awards during his scientific career including the Spanish National Award for Oncology Research.
Dr. Montero is a motivated cancer researcher with a strong background in molecular biology, preclinical research, cell-based assays, biomarkers and discovery of novel anti-cancer therapies. He is a team player with an entrepreneurial spirit and one clear goal: to find new cures for kids with cancer.